-
Venetoclax plus hypomethylating agents as a bridge to transplant or donor lymphocyte infusion in relapsed/refractory acute myeloid leukemia
Verdeyen, K., Reuvekamp, T., Van der Velden, W. J. F. M., Wouters, B. J., Von dem Borne, P. A., Van Rhenen, A., Lissenberg-Witte, B. I., Van Lammeren, D., Van Sluis, G. L., De Jongh, E., Fiets, R. B., Corsten, M. F., Van der Spek, A. C., Gerrits, A. M., Van Bladel, E. R., Tick, L. W., De Weerdt, O., Van Zaane, B., Cruijsen, M. J. & Posthuma, E. F. M. & 4 others, , 18 Sept 2025, (E-pub ahead of print) In: Haematologica.Research output: Contribution to journal › Article › Academic › peer-review
-
Computational measurable residual disease assessment in acute myeloid leukemia: a retrospective validation in the HOVON-SAKK-132 trial
Mocking, T. R., Haaksma, L. H., Reuvekamp, T., Kelder, A., Scholten, W. J., Ngai, L. L., Breems, D. A., Fischer, T., Gjertsen, B. T., Griškevičius, L., Juliusson, G., Maertens, J. A., Manz, M. G., Pabst, T., Passweg, J. R., Porkka, K., Valk, P. J. M., Gradowska, P., Löwenberg, B. & de Leeuw, D. C. & 5 others, , 13 Sept 2025, (E-pub ahead of print) In: Leukemia.Research output: Contribution to journal › Article › Academic › peer-review
-
Surface downmodulation of TIM3 safeguards healthy cells but not acute myeloid leukemia from CAR T-cell therapy
van der Schans, J. J., Vishwasrao, P., Poels, R., Antti, M., Wang, Z., Quik, M., van Arkel, J., Reuvekamp, T., van de Donk, N. W. C. J., Themeli, M., Ossenkoppele, G. J., van de Loosdrecht, A. A., Richards, R. & Mutis, T., 1 Jul 2025, In: HemaSphere. 9, 7, e70155.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
